Li Y et al. |
Dual carbamoylations on the polyketide and glycosyl moiety by asm21 result in extended ansamitocin biosynthesis. |
2011 |
Chem. Biol. |
pmid:22195559
|
Wang H et al. |
Albumin nanoparticle encapsulation of potent cytotoxic therapeutics shows sustained drug release and alleviates cancer drug toxicity. |
2017 |
Chem. Commun. (Camb.) |
pmid:28195282
|
Fishkin N et al. |
A novel pathway for maytansinoid release from thioether linked antibody-drug conjugates (ADCs) under oxidative conditions. |
2011 |
Chem. Commun. (Camb.) |
pmid:21874179
|
Akimoto H et al. |
Chemical modification of ansamitocins. II. Synthesis of 3-epimaytansionoids via 3-maytansinones. |
1984 |
Chem. Pharm. Bull. |
pmid:6437689
|
Kawai A et al. |
Chemical modification of ansamitocins. III. Synthesis and biological effects of 3-acyl esters of maytansinol. |
1984 |
Chem. Pharm. Bull. |
pmid:6441645
|
Cassady JM et al. |
Recent developments in the maytansinoid antitumor agents. |
2004 |
Chem. Pharm. Bull. |
pmid:14709862
|
Wu Y et al. |
N-methylation of the amide bond by methyltransferase asm10 in ansamitocin biosynthesis. |
2011 |
Chembiochem |
pmid:21681880
|
Harmrolfs K et al. |
Cyclization of synthetic seco-proansamitocins to ansamitocin macrolactams by Actinosynnema pretiosum as biocatalyst. |
2010 |
Chembiochem |
pmid:21077088
|
Taft F et al. |
Highly active ansamitocin derivatives: mutasynthesis using an AHBA-blocked mutant. |
2008 |
Chembiochem |
pmid:18381586
|
Kubota T et al. |
Determination of the cryptic stereochemistry of the first PKS chain-extension step in ansamitocin biosynthesis by Actinosynnema pretiosum. |
2006 |
Chembiochem |
pmid:16927319
|
Knobloch T et al. |
Mutational biosynthesis of ansamitocin antibiotics: a diversity-oriented approach to exploit biosynthetic flexibility. |
2011 |
Chembiochem |
pmid:22238146
|
Seidel K et al. |
Synthesis of Magnetic-Nanoparticle/Ansamitocin Conjugates-Inductive Heating Leads to Decreased Cell Proliferation In Vitro and Attenuation Of Tumour Growth In Vivo. |
2017 |
Chemistry |
pmid:28585348
|
Wang LL et al. |
A Bio-Chemosynthetic Approach to Superparamagnetic Iron Oxide-Ansamitocin Conjugates for Use in Magnetic Drug Targeting. |
2017 |
Chemistry |
pmid:27935144
|
Mancuso L et al. |
Preparation of thermocleavable conjugates based on ansamitocin and superparamagnetic nanostructured particles by a chemobiosynthetic approach. |
2014 |
Chemistry |
pmid:25346489
|
Taft F et al. |
Combined muta- and semisynthesis: a powerful synthetic hybrid approach to access target specific antitumor agents based on ansamitocin P3. |
2012 |
Chemistry |
pmid:22170289
|
Kwon Y et al. |
Telangiectasia and Pulmonary Arterial Hypertension Following Treatment With Trastuzumab Emtansine: A Case Report. |
2016 |
Chest |
pmid:27055712
|
Bertholjotti I |
[Antibody-drug conjugate--a new age for personalized cancer treatment]. |
2011 |
Chimia (Aarau) |
pmid:22026193
|
Gligorov J et al. |
Emilia: use cunning to survive cancer. |
2018 |
Chin Clin Oncol |
pmid:29307196
|
Ricci F and Le Tourneau C |
Trastuzumab emtansine in HER2-positive metastatic breast cancer: what is the best sequence? |
2018 |
Chin Clin Oncol |
pmid:29156892
|
Bander NH et al. |
Antibody-drug conjugate technology development for hematologic disorders. |
2012 |
Clin Adv Hematol Oncol |
pmid:23072775
|